Skip to main content
. 2021 May 31;11:630672. doi: 10.3389/fonc.2021.630672

Figure 2.

Figure 2

CTC NGS analysis of cancer-related gene mutations in lung cancer patients. (A) Proportion of mutated genes in 19 lung cancer patients. (B) >10%, >30%, >50% of patients with mutated genes.